Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Biochem Cell Biol ; 43(9): 1402-11, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21689781

RESUMO

The transfer of cholesterol to mitochondria, which might involve the phosphorylation of proteins, is the rate-limiting step in human placental steroidogenesis. Protein kinase A (PKA) activity and its role in progesterone synthesis by human placental mitochondria were assessed in this study. The results showed that PKA and phosphotyrosine phosphatase D1 are associated with syncytiotrophoblast mitochondrial membrane by an anchoring kinase cAMP protein-121. The ³²P-labeled of four major proteins was analyzed. The specific inhibitor of PKA, H89, decreased progesterone synthesis in mitochondria while in mitochondrial steroidogenic contact sites protein-phosphorylation was diminished, suggesting that PKA plays a role in placental hormone synthesis. In isolated mitochondria, PKA activity was unaffected by the addition of cAMP suggesting a constant activity of this kinase in the syncytiotrophoblast. The presence of PKA and phosphotyrosine phosphatase D1 anchored to mitochondria by an anchoring kinase cAMP protein-121 indicated that syncytiotrophoblast mitochondria contain a full phosphorylation/dephosphorylation system.


Assuntos
Proteínas Quinases Dependentes de AMP Cíclico/antagonistas & inibidores , Isoquinolinas/farmacologia , Mitocôndrias/efeitos dos fármacos , Placenta/efeitos dos fármacos , Progesterona/biossíntese , Sulfonamidas/farmacologia , Trofoblastos/efeitos dos fármacos , Proteínas de Ancoragem à Quinase A/metabolismo , Ensaios Enzimáticos , Feminino , Humanos , Mitocôndrias/enzimologia , Mitocôndrias/metabolismo , Consumo de Oxigênio , Fosfoproteínas/metabolismo , Fosforilação , Placenta/citologia , Placenta/metabolismo , Gravidez , Estabilidade Proteica , Proteínas Tirosina Fosfatases não Receptoras/metabolismo , Trofoblastos/enzimologia , Trofoblastos/metabolismo
2.
Mol Biochem Parasitol ; 162(2): 123-33, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18765260

RESUMO

The tegumental membrane of Taenia crassiceps cysticerci contains an ATP-diphosphohydrolase (EC 3.6.1.5) which hydrolyzes purine and pyrimidine nucleoside 5'-di- and 5'-triphosphates at an optimum pH of 8.5. It is Mg(2+)-dependent and insensitive to classical ATPase and phosphatase inhibitors. In solubilized tegumental membrane the Km values varied from 220 to 480 microM and the V(max) from 370 to 748 nmol of Pi release/mg/min for nucleoside triphosphates (ATP, GTP, CTP, UTP, and TTP); for nucleoside diphosphates (ADP, GDP, CDP, and UDP) the Km values were from 260 to 450 microM and the V(max) from 628 to 1134 nmol of Pi release/mg/min. An antibody specific to CD39 shows cross-reactivity with T. crassiceps ATP-diphosphohydrolase, revealing a single protein of approximately 80 kDa. Incubation of ATP-diphosphohydrolase with FSBA inhibited ATPase and ADPase activities by 85-90%. Immunoblot analyses, the competition plot, similar inhibition by free nucleotides, the lack of effect of Mg(2+) at high concentrations, and the inactivation by FSBA of ATPase and ADPase activity strongly suggest that a single enzyme catalyzes the hydrolysis of all these nucleotides. The mechanism of ATP hydrolysis shows that ATP-diphosphohydrolase releases ADP during the catalytic cycle. Incubation of intact cysticerci with FSBA caused 70-80% inhibition of ATPase and ADPase activities, indicating that the active site of the ATP-diphosphohydrolase is oriented to the external surface of the tegument of T. crassiceps. The importance of this enzyme in the parasite-host relationship is discussed.


Assuntos
Adenosina/análogos & derivados , Marcadores de Afinidade/farmacologia , Apirase/antagonistas & inibidores , Taenia/enzimologia , Adenosina/farmacologia , Animais , Antígenos CD/química , Antígenos CD/metabolismo , Apirase/química , Apirase/metabolismo , Inibidores Enzimáticos/farmacologia , Concentração de Íons de Hidrogênio , Cinética , Taenia/efeitos dos fármacos , Taenia/metabolismo
3.
Int J Biochem Cell Biol ; 40(5): 901-8, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18069041

RESUMO

The peripheral benzodiazepine receptor and protein kinase A have been proposed to modulate placental steroidogenesis. Binding of the radioactive benzodiazepine PK 11195 has been observed in membranes isolated from whole human placenta, but the presence of the peripheral benzodiazepine receptors, now called translocator protein, does not seem to be indispensable. We hypothesized that cAMP analogs could induce the translocator protein expression in BeWo cells increasing steroidogenesis in the presence of benzodiazepines. The effect of two benzodiazepines and of 8-Br-cAMP on steroidogenesis in BeWo cells or in isolated human placental mitochondria was studied. Benzodiazepines did not modify progesterone synthesis in either system. Progesterone increased three times in BeWo cells incubated in the presence of 8-Br-cAMP. The translocator protein was not identified by western blot in mitochondria isolated from either the human placenta or BeWo cells but it was present in isolated rat testicular mitochondria. Neither was it observed in isolated mitochondria from BeWo cells incubated with 8-Br-cAMP. An inhibitor of protein kinase A activity, H89, at 25 microM inhibited 90% the steroidogenesis in BeWo cells, even in the presence of 8-Br-cAMP, but protein phosphorylation in mitochondria increased in the presence of H89, suggesting that protein kinase A modulates the phosphorylation cycle of mitochondrial proteins. The results suggest that placental steroidogenesis is regulated via activation of protein kinase A modulated by cAMP.


Assuntos
Proteínas Quinases Dependentes de AMP Cíclico/fisiologia , Placenta/metabolismo , Progesterona/biossíntese , Receptores de GABA-A/metabolismo , 8-Bromo Monofosfato de Adenosina Cíclica/farmacologia , Benzodiazepinonas/farmacologia , Linhagem Celular , Proteínas Quinases Dependentes de AMP Cíclico/antagonistas & inibidores , Humanos , Isoquinolinas/farmacologia , Placenta/efeitos dos fármacos , Placenta/enzimologia , Inibidores de Proteínas Quinases/farmacologia , Sulfonamidas/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...